Abluminus NP

Sirolimus coated stent - Polymer-free

Sirolimus based nano carrier eluting stent system.

Advantages

• Sirolimus acts cytostatic - not cytotoxic
• Optimum Sirolimus binding to the balloon surface thanks to Nanolute technology
• 100% balloon coating
• Slow tissue absorption
• Effective Sirolimus transfer into deeper vessel layers
• High Sirolimus bioavailability

Specifications

Abluminal Coating
Drug is coated on the abluminal side only.
Leading to mono directional drug release & less systemic exposure of drug which leads to faster healing.

Fusion Coating
Drug is coated on stent as well as exposed parts of balloon & coated on the proximal and distal ends.
Helps to address the entire disease area of lesion and address focal restenosis and edge restenosis.

Polymer Free Nano Carrier Drug Delivery
Designed for acute as well as sustained drug transfer in arterial wall – leading to less chronic inflammation and improved vascular healing.

Polymer Free Coating
Proposed the shorter DAPT which helps to reduced bleeding risk in patients with high bleeding risk.